Custom Monoclonal Antibody Service
Hybridoma technology is a technology featuring effective usage of innate functions of both immune cells and cancers to generate monoclonal antibodies (mAbs)-producing hybridoma cell-lines against specific antigens of interest. Such technology has opened r
2018-07-13
